Stocks and Investing Stocks and Investing
Tue, March 21, 2023
Mon, March 20, 2023

Ed Arce Reiterated (AKRO) at Strong Buy and Held Target at $64 on, Mar 20th, 2023


Published on 2024-10-28 02:20:55 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Reiterated "Akero Therapeutics, Inc." (AKRO) at Strong Buy and Held Target at $64 on, Mar 20th, 2023.

Ed has made no other calls on AKRO in the last 4 months.



There is 1 other peer that has a rating on AKRO. Out of the 1 peers that are also analyzing AKRO, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Michael Ulz of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $65 on, Friday, January 27th, 2023
Contributing Sources